Management of infection and febrile neutropenia in patients with solid cancer

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Virizuela JA
  • Carratalà J
  • Aguado JM
  • Vicente D
  • Ruiz M
  • Ruiz I
  • Marco F
  • Lizasoain M
  • Jiménez-Fonseca P
  • Gudiol C
  • Cassinello J
  • Carmona-Bayonas A
  • Aguilar M
  • Cruz JJ

Grupos

Abstract

An expert group from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC, for its acronym in Spanish) and the Spanish Society of Medical Oncology (SEOM, for its acronym in Spanish) have reviewed the main aspects to be considered when evaluating patients with solid cancer and infectious complications contained in this article. Recommendations have, therefore, been put forth regarding the prophylaxis of the most prevalent infections in these patients, the use of vaccines, measures to control infection through vascular catheters, and preventing infection in light of certain surgical maneuvers. The following is a revision of the criteria for febrile neutropenia management and the use of colony-stimulating factors and closes with several guidelines for treating the cancer patient with serious infection. The document concludes with a series of measures to control hospital infection.

Datos de la publicación

ISSN/ISSNe:
1699-048X, 1699-3055

Clinical & Translational Oncology  SPRINGER INT PUBL AG

Tipo:
Article
Páginas:
557-570
PubMed:
26577106
Factor de Impacto:
0,774 SCImago
Cuartil:
Q2 SCImago

Citas Recibidas en Web of Science: 17

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Cancer; Febrile neutropenia; Infection; Prophylaxis; Risk factors

Campos de Estudio

Cita

Compartir